111

111 EBITDA Growth YoY

The Year-over-Year EBITDA Growth of 111 (YI) as of Oct 31, 2026 is -574.37 %. In the previous year, Year-over-Year EBITDA Growth was 100.63 % — a change of -670.74% (lower).

EBITDA Growth YoY

-574.37 %

YoY

-670.74%

Last updated:

Year-over-Year EBITDA Growth of 111 is 2025 -574.37 % . Year-over-Year EBITDA Growth of 111 was 2024 100.63 % . It decreases by -670.74% lower compared to the previous year.

The 111 EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2018
-57.61 CNY
Jan 1, 2019
-23.26 CNY
Jan 1, 2020
4.09 CNY
Jan 1, 2021
-35.67 CNY
Jan 1, 2022
43.53 CNY
Jan 1, 2023
8.16 CNY
Jan 1, 2024
100.63 CNY
Jan 1, 2025
-574.37 CNY
The 111 EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-574.37 %-670.74%
100.63 %+1,133.49%
8.16 %-81.26%
43.53 %-222.03%
-35.67 %-971.37%
4.09 %-117.60%
-23.26 %-59.62%
-57.61 %-290.35%
30.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

111 Stock analysis

What does 111 do? 111 Inc, trading under the ticker YI and ISIN US68247Q2012, is a company based in Shanghai, China, operating within the Consumer Staples sector and Retail industry. The company went public on September 12, 2018. According to the provided information, 111 Inc is engaged in the provision of pharmaceutical products and medical services through online retail pharmacy and an indirect offline pharmacy network. The company's website is http://gangling.111.com.cn/. The employee count provided in the user message is 144, though the source description mentions 1,932 full-time employees, which is inconsistent. The company focuses on online medical services, drug purchasing, and health management services utilizing internet and information technology. It primarily serves the domestic market in China. The company's headquarters are located in Shanghai, Shanghai, and it operates with a focus on retail and consumer staples within the pharmaceutical and healthcare services domain. 111 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 111 stock

Year-over-Year EBITDA Growth of 111 is -574.37 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth 111 since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's 111 historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — 111

All Key Metrics — 111